Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CCR5 ELISA Kit (AC3801)
Cat.#: ASET-2390
Specifications
Description Human CCR5 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CCR5 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.61 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2158 Human GDNF ELISA Kit (AC3569) Quantitative inquiry ASET-1264 Rat TSH beta ELISA Kit (AC2675) Quantitative inquiry ASET-2484 Mouse Nrg4 ELISA Kit (AC3895) Quantitative inquiry ASET-2446 Human Tau ELISA Kit (AC3857) Quantitative inquiry ASET-1782 Mouse Dopamine Transporter ELISA Kit (AC3193) Quantitative inquiry ASET-1948 Mouse IRS1 ELISA Kit (AC3359) Quantitative inquiry ASET-1239 Mouse AGRP ELISA Kit (AC2650) Quantitative inquiry ASET-1765 Mouse POMC ELISA Kit (AC3176) Quantitative inquiry ASET-1666 Porcine Ghrelin ELISA Kit (AC3077) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket